• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Canada·Healthcare·JWCAF
Share

James E. Wagner Cultivation Corporation Stocks

$ 0Last Updated 06.11.2026

Issuer Rating

3/7
Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

$ 10942

$ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

James E. Wagner Cultivation Corporation, operating primarily through its subsidiary, James E. Wagner Cultivation Ltd., is a Canadian enterprise focused on the growth and supply of cannabis for medical purposes. The company distinguishes itself by committing to the production of pure and uniform cannabis products, leveraging its exclusive aeroponic cultivation technology, dubbed GrowthSTORM. This firm was established in 2007 and has its main operational base in Kitchener, Canada.

Company Valuation

Greatly undervalued
7/7

Considering past and projected metrics, the stock is distinctly 'cheaper' than its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

08.11.2026 22:01

IPO roundup: OpenAI valuation gains on Anthropic, Nebius rival Nscale takes a hit

08.11.2026 15:01

Getting Stuck on the Same Thing: How News Concentration Affects Investors' Decisions

07.11.2026 23:21

'Air is coming out of the AI bubble': Strategists urge investors to buy after rout

07.11.2026 19:13

Berkshire has sharply accelerated its share buybacks. Should investors buy these shares?

07.11.2026 17:01

Small caps last week: Inovio approval, Alstom guidance cut, Once Upon a Farm recall

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026